4//SEC Filing
Derynck Mika K 4
Accession 0001209191-23-023664
CIK 0001672619other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:17 PM ET
Size
5.4 KB
Accession
0001209191-23-023664
Insider Transaction Report
Form 4
Derynck Mika K
Director
Transactions
- Award
Stock Option (right to buy)
2023-02-23+27,567→ 27,567 totalExercise: $25.28Exp: 2033-02-23→ Common Stock (27,567 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option will vest on March 23, 2023 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001865125
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:17 PM ET
- Size
- 5.4 KB